Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH announcement banner was added with links to transition updates and a notice about the agency’s shift from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T16:49:35.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:30:31.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:28:55.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating restricted access to the study record. As a result, only basic site chrome is visible while the main study details are inaccessible.
    Difference
    18%
    Check dated 2026-09-20T22:48:23.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.5 to v3.6.6, indicating a small maintenance update to the page.
    Difference
    0.1%
    Check dated 2026-08-30T16:31:07.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a minor site version update. This reflects an under-the-hood update to the interface rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-08-09T09:17:13.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.